Reaction

Ventricular Hypertrophy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,499 reports · 100 co-occurring drugs

As of the last recalculation, Ventricular Hypertrophy appears in 2,499 FAERS reports alongside 100 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 20.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Zidovudine	33	20.8	20.9
Agalsidase Beta	22	20.0	20.0
Captopril	21	18.3	18.4
Enalapril Maleate	48	16.4	16.5
Cimetidine	18	15.7	15.7
Mometasone	32	14.7	14.7
Amlodipine Besylate And Benazepril Hydrochloride	16	14.5	14.5
Losartan Potassium And Hydrochlorothiazide	19	13.7	13.7
Darunavir	24	13.3	13.4
Digoxin	110	13.3	13.3
Ampicillin	13	13.1	13.2
Ampicillin Sodium	13	13.1	13.2
Quinine	13	12.7	12.7
Raltegravir	24	12.2	12.2
Diltiazem Hydrochloride	47	11.5	11.5
Carisoprodol	26	11.5	11.5
Isosorbide Mononitrate	28	11.4	11.4
Tolterodine Tartrate	12	11.2	11.2
Gemfibrozil	20	11.1	11.1
Glyburide	31	10.8	10.8
Vitamin E	40	10.7	10.8
Isosorbide Dinitrate	24	10.3	10.3
Paroxetine Hydrochloride	101	9.6	9.6
Nitroglycerin	59	9.4	9.4
Anti-Thymocyte Globulin (Rabbit)	9	9.3	9.3
Ipratropium Bromide	38	9.0	9.0
Testosterone	25	9.0	9.0
Ritonavir	31	8.9	8.9
Labetalol	14	8.8	8.8
Cephalexin	22	8.5	8.5
Ritonavir 100 Mg	15	8.4	8.4
Meperidine Hydrochloride	9	8.2	8.2
Meclizine Hcl 12.5Mg	13	8.0	8.0
Meclizine Hcl 25Mg	13	8.0	8.0
Meclizine Hcl 12.5 Mg	13	8.0	8.0
Meclizine Hcl 25 Mg	13	8.0	8.0
Salmeterol Xinafoate	8	7.8	7.8
Estrogens, Conjugated	54	7.7	7.7
Nifedipine	43	7.7	7.7
Amitriptyline Hydrochloride	16	7.6	7.6
Conjugated Estrogens	52	7.6	7.6
Olanzapine Pamoate	35	7.2	7.2
Enalapril	47	7.2	7.2
Epoetin Alfa	10	7.1	7.1
Insulin	46	7.0	7.0
Senna Leaf	19	6.9	6.9
Atenolol	106	6.9	6.9
Sennosides 8.6 Mg Tablets	17	6.8	6.8
Senna	17	6.8	6.8
Warfarin Sodium	37	6.7	6.7
Metolazone	9	6.7	6.7
Meclizine	13	6.7	6.7
Valsartan	81	6.6	6.6
Doxazosin	22	6.6	6.6
Amlodipine Besylate	111	6.6	6.6
Aspirin 325 Mg	352	6.5	6.5
Aspirin 81 Mg	352	6.5	6.5
Ibuprofen And Diphenhydramine Citrate	18	6.5	6.5
Ciprofloxacin Hydrochloride And Hydrocortisone	16	6.4	6.4
Basiliximab	9	6.4	6.4
Aspirin	362	6.4	6.4
Gentamicin	10	6.4	6.4
Sertraline Hydrochloride	87	6.3	6.3
Doxazosin Mesylate	26	6.1	6.1
Amlodipine Besylate And Valsartan	8	6.0	6.0
Furosemide	261	5.9	5.9
Atorvastatin Calcium	163	5.8	5.8
Tafamidis	8	5.7	5.7
Naproxen Sodium Tablet, Coated	9	5.6	5.6
Naproxen Sodium, Coated Tablets	9	5.6	5.6
Naproxen Sodium 220Mg	9	5.5	5.5
Extended Phenytoin Sodium	11	5.5	5.5
Glipizide	39	5.4	5.4
Fluticasone Furoate And Vilanterol Trifenatate	23	5.4	5.4
Pioglitazone	27	5.2	5.2
Loperamide Hcl	8	5.2	5.2
Sotalol Hydrochloride	10	5.0	5.0
Sevoflurane	5	5.0	5.0
Hydrocodone Bitartrate	25	4.8	4.8
Isopropyl Alcohol	19	4.7	4.7
Bosentan	28	4.7	4.7
Atazanavir	8	4.6	4.7
Ethyl Alcohol	15	4.6	4.6
Conjugated Estrogens And Medroxyprogesterone Acetate	13	4.6	4.6
Clozapine	67	4.5	4.5
Derma Foam Excel Hand Sanitizer	4	4.2	4.2
Ethanol	4	4.2	4.2
Timolol	6	4.1	4.1
Alcohol	19	4.1	4.1
Pseudoephedrine Hcl	5	3.8	3.8
Rocuronium Bromide	5	3.5	3.5
Dofetilide	4	3.2	3.2
Diclofenac Potassium, Film Coated	3	3.0	3.0
Diclofenac Potassium Tablets	3	3.0	3.0
Emtricitabine And Tenofovir Disoproxil Fumarate	15	2.7	2.8
Emtricitabine And Tenofovir Alafenamide	3	2.2	2.2
Somatropin	19	2.2	2.2
Minoxidil Foam 5% (Womens)	8	2.0	2.0
Minoxidil	8	1.5	1.5
Cinacalcet Hydrochloride	6	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.